Medtronic Accrued Compensation increased by 21.2% to $2.58B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.2%, from $2.28B to $2.58B. Over 4 years (FY 2021 to FY 2025), Accrued Compensation shows relatively stable performance with a 0.3% CAGR.
An increase often reflects higher performance-based bonus accruals or headcount growth, while a decrease may signal lower variable compensation payouts.
This reflects the liability for earned but unpaid employee salaries, bonuses, and benefits at the balance sheet date. It...
Commonly reported by service-oriented firms and asset managers as a primary operating liability.
accrued_compensation| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.90B | $1.93B | $2.15B | $2.12B | $1.77B | $1.72B | $2.01B | $1.95B | $1.70B | $1.76B | $2.17B | $2.38B | $1.78B | $1.89B | $2.28B | $2.51B | $2.02B | $2.13B | $2.58B |
| QoQ Change | — | +1.7% | +11.3% | -1.4% | -16.4% | -2.9% | +16.6% | -2.9% | -13.0% | +3.7% | +23.7% | +9.2% | -25.2% | +6.6% | +20.5% | +10.2% | -19.8% | +5.6% | +21.2% |
| YoY Change | — | — | — | — | -6.7% | -11.0% | -6.7% | -8.1% | -4.4% | +2.1% | +8.3% | +21.9% | +4.8% | +7.7% | +4.9% | +5.9% | +13.6% | +12.5% | +13.2% |